Eric Aboagye
Professor of Cancer Pharmacology & Molecular Imaging at Imperial College London.
Eric Aboagye is Professor of Cancer Pharmacology & Molecular Imaging and Director of the CRUK-EPSRC-MRC-NIHR Comprehensive Cancer Imaging Centre. He joined the college after a PhD at the CRUK Beatson Laboratories in Glasgow, UK and post-doc fellowship at The Johns Hopkins University & Hospital in Baltimore, USA. His group is interested in the discovery and development of new methods for experimental and clinical cancer molecular imaging. In the past 5 years, the team has invented and translated three novel cancer diagnostics into human application. He has acted as an advisor to GE-Healthcare, GSK, Roche and Novartis.
Visit website: https://www.imperial.ac.uk/people/eric.aboagye
See also: Imperial College London (ICL) - Public research university with an international reputation for excellence in teaching and research
Details last updated 04-Jan-2020
Eric Aboagye News
AI makes ovarian cancer prognosis and treatment recommendation
Pharmaceutical Business Review - 18-Feb-2019
More accurate than current methods - we'll hear this a lot with AI in healthcare
Read more...